4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Beijing Tong Ren Tang Chinese Medicine Company Limited (3613) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Wan Chai, Hong Kong with about 763 employees. Its market capitalization is roughly HK$5 billion. In the fiscal year ended 2025-12-31, 3613 reported HK$1.5B in revenue and HK$397M in net income.
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals. It operates through Hong Kong, Mainland China, and Overseas segments.
Interactive charts & full statements → Open the 3613 valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | HK$1.5B | HK$1.6B | HK$1.5B | HK$1.7B |
| Gross Profit | HK$926M | HK$1.1B | HK$1.0B | HK$1.2B |
| Operating Income (EBIT) | HK$536M | HK$574M | HK$639M | HK$815M |
| Net Income | HK$397M | HK$500M | HK$540M | HK$646M |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (HK$293M) | (HK$276M) | (HK$276M) | (HK$444M) | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | HK$4.7B | HK$4.6B | HK$4.4B | HK$4.2B | — |
| Total Liabilities | HK$292M | HK$313M | HK$414M | HK$486M | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 3613 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms